Deslorelin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Deslorelin, covering 2024-08-28 to 2024-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease [Phase 2]